Kidneys from patients with small renal tumours: A novel source of kidneys for transplantation

BJU International

Volumn 102, Issue 2, 2008, Pages 188-193

  Nicol, David L ^a,b   Preston, John M ^b   Wall, Daryl R ^b   Griffin, Anthony D ^b   Campbell, Scott B ^b   Isbel, Nicole M ^b   Hawley, Carmel M ^b   Johnson, David W ^b  

^a PRINCESS ALEXANDRA HOSPITAL   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Live donors; Novel donor source; Renal transplantation; Renal tumours

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; OKT 3; PREDNISOLONE;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; ECHOGRAPHY; GRAFT SURVIVAL; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY DONOR; KIDNEY TRANSPLANTATION; KIDNEY TUMOR; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; THORAX RADIOGRAPHY; CHRONIC KIDNEY DISEASE; GRAFT RECIPIENT; KIDNEY CANCER; KIDNEY CARCINOMA; METASTASIS; NOTE; PARTIAL NEPHRECTOMY; PATIENT SAFETY; TUMOR RECURRENCE; TUMOR VOLUME;

EID: 45449105828     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2008.07562.x     Document Type: Article

References (36)

1. Cecka JM. The OPTN/UNOS renal transplant registry. Clin Transpl 2005 1 16
2. Australian and New Zealand Dialysis and Transplant Registry Annual Report. Available at: http://www.anzdata.org.au/ANZDATA/AnzdataReport/report. htm. Accessed June 2007
3. Johnson DW, Herzig K, Purdie D et al. A comparison of the effects of dialysis and renal transplantation on the survival of older uremic patients. Transplantation 2000 69 : 794 9
4. Mathew A, Devesa SS, Fraumeni JF Jr, Chow WH. Global increases in kidney cancer incidence 1973-92. Eur J Cancer 2002 11 : 171 8
5. Chow WH, Devesa SS, Warren JL, Fraumeni JF Jr. Rising incidence of renal cell cancer in the United States. JAMA 1999 281 : 1628 31
6. Nicol D. Issues in the diagnosis of renal cell carcinoma. BJU Int 2000 86 : 298 303
7. Wunderlich H, Schumann S, Jantitzky V et al. Increase of renal cell carcinoma incidence in central Europe. Eur Urol 1998 33 : 538 41
8. Hellsten S, Johnsen J, Berge T, Linell F. Clinically unrecognized renal cell carcinoma. Diagnostic and pathological aspects. Eur Urol 1990 18 (Suppl. 2 2 3
9. Volpe A, Panzarella T, Rendon RA, Haider MA, Kondylis FI, Jewett MA. The natural history of incidentally detected small renal masses. Cancer 2004 100 : 738 45
10. Chawla SN, Crispen PL, Hanlon AL, Greenberg RE, Chen DY, Uzzo RG. The natural history of observed enhancing renal masses: meta-analysis and review of the world literature. J Urol 2006 175 : 425 31
11. Curti BD. Renal cell carcinoma. JAMA 2004 292 : 97 100
12. Di Silverio F, Casale P, Colella D, Andrea L, Seccareccia F, Sciarra A. Independent value of tumor size and DNA ploidy for the prediction of disease progression in patients with organ-confined renal cell carcinoma. Cancer 2000 88 : 835 43
13. Bosniak MA. The small (less than or equal to 3.0 cm) renal parenchymal tumour: detection, diagnosis and controverises. Radiology 1991 179 : 307 17
14. Joniau S, Vander Eeckt K, Van Poppel H. The indications for partial nephrectomy in the treatment of renal cell carcinoma. Nat Clin Pract Urol 2006 3 : 198 205
15. Whang M, O'Toole K, Bixon R et al. The incidence of multifocal renal cell carcinoma in patients who are candidates for partial nephrectomy. J Urol 1995 154 : 968 70
16. Delakas D, Karyotis I, Daskalopoulos G, Terhorst B, Lymberopoulos S, Cranidis A. Nephron-sparing surgery for localized renal cell carcinoma with a normal contralateral kidney: a European three-center experience. Urology 2002 60 : 998 1002
17. Novick AC. Nephron-sparing surgery for renal cell carcinoma. Annu Rev Med 2002 53 : 393 407
18. Gill IS, Matin SF, Desai MM et al. Comparative analysis of laparoscopic versus open partial nephrectomy for renal tumors in 200 patients. J Urol 2003 170 : 64 8
19. Porter MP, Lin DW. Trends in renal cancer surgery and patient provider characteristics associated with partial nephrectomy in the United States. Urol Oncol 2007 25 : 298 302
20. Hollenbeck BK, Taub DA, Miller DC, Dunn RL, Wei JT. National utilization trends of partial nephrectomy for renal cell carcinoma: a case of underutilization? Urology 2006 67 : 254 9
21. Rabbat CG, Thorpe KE, Russell JD, Churchill DN. Comparison of mortality risk for dialysis patients and cadaveric first renal transplant recipients in Ontario, Canada. J Am Soc Nephrol 2000 11 : 917 22
22. Satayathum S, Pisoni RL, McCullough KP et al. Kidney transplantation and wait-listing rates from the international Dialysis Outcomes and Practice Patterns Study (DOPPS). Kidney Int 2005 68 : 330 7
23. Marumo K, Kanayama H, Miyao N et al. Prevalence of renal cell carcinoma: a nation-wide survey in Japan, 2002. Int J Urol 2007 14 : 479 82
24. Penn I. Primary kidney tumors before and after renal transplantation. Transplantation 1995 59 : 480 5
25. Barama A, St-Louis G, Nicolet V, Hadjeres R, Daloze P. Renal cell carcinoma in kidney allografts: a case series from a single center. Am J Transplant 2005 5 : 3015 8
26. Roupret M, Peraldi MN, Thaunat O et al. Renal cell carcinoma of the grafted kidney: how to improve screening and graft tracking. Transplantation 2004 77 : 146 8
27. Krishnamurthi V, Novick AC. Nephron-sparing surgery in a renal allograft. Urology 1997 50 : 132 4
28. Aron M, Hegarty NJ, Remer E, O'Malley C, Goldfarb D, Kaouk JH. Percutaneous radiofrequency ablation of tumor in transplanted kidney. Urology 2007 69 : 778.e5 7
29. Suranyi MG, Hogan PG, Falk MC et al. Advanced donor-origin melanoma in a renal transplant recipient: immunotherapy, cure, and retransplantation. Transplantation 1998 66 : 655 61
30. Milton CA, Barbara J, Cooper J, Rao M, Russell C, Russ G. The transmission of donor-derived malignant melanoma to a renal allograft recipient. Clin Transplant 2006 20 : 547 50
31. Carver BS, Zibari GB, McBride V, Venable DD, Eastham JA. The incidence and implications of renal cell carcinoma in cadaveric renal transplants at the time of organ recovery. Transplantation 1999 67 : 1438 40
32. Lane BR, Babineau D, Kattan MW et al. A preoperative prognostic nomogram for solid enhancing renal tumours 7 cm or less amenable to partial nephrectomy. J Urol 2007 178 : 429 34
33. Glassman D, Chawla SN, Waldman I et al. Correlation of pathology with tumour size of renal masses. Can J Urol 2007 14 : 3616 20
34. Huang WC, Levey AS, Serio AM et al. Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort study. Lancet Oncol 2006 7 : 735 40
35. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004 351 : 1296 305
36. Hollenbeck BK, Taub DA, Miller DC, Dunn RL, Wei JT. National utilization trends of partial nephrectomy for renal cell carcinoma: a case of underutilization? Urology 2006 67 : 254 9